Baxter (BAX) Announces Acquisition of PerClot Polysaccharide Hemostatic System from CryoLife (CRY)

Go back to Baxter (BAX) Announces Acquisition of PerClot Polysaccharide Hemostatic System from CryoLife (CRY)

Baxter International (BAX) PT Lowered to $90 at Stifel

July 29, 2021 1:06 PM EDT

Stifel analyst Rick Wise lowered the price target on Baxter International (NYSE: BAX) to $90.00 (from $95.00) while maintaining a Buy rating.

The analyst commented, "Overall, Baxters 2Q21 results seemed mixed, if not slightly-disappointing. Total sales were basically in-line with Stifel/Consensus (+8% operationally), aided... More